The WHO World Alliance for Patient Safety: A new challenge or an old one neglected?

Drug Safety

Volumn 28, Issue 5, 2005, Pages 379-386

  Edwards, I Ralph ^a  

^a UPPSALA MONITORING CENTRE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

ADVERSE DRUG REACTION; CLINICAL PRACTICE; COOPERATION; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; FOLLOW UP; GOOD CLINICAL PRACTICE; HEALTH CARE QUALITY; HUMAN; INTERPERSONAL COMMUNICATION; LEARNING; MEDICAL ERROR; MEDICAL PRACTICE; PATIENT CARE; PRESCRIPTION; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; SAFETY; THERAPEUTIC ERROR; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

CONSUMER PRODUCT SAFETY; DELIVERY OF HEALTH CARE; DRUG THERAPY; HUMANS; INTERNATIONAL AGENCIES; WORLD HEALTH ORGANIZATION;

EID: 19544362546     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-200528050-00002     Document Type: Review

References (21)

1. Vincent C, Neale G, Woloshynowych M. Adverse events in British hospitals: preliminary retrospective record review. BMJ 2001; 322: 517-9
2. Resolution WHA55.18. Quality of care: patient safety. In: Fifty-fifth World Health Assembly, Geneva, 13-18 May 2002. Volume 1: Resolutions and decisions. Geneva: World Health Organization; 2002. WHO document WHA55/2002/REC/1
3. Schioler T, Lipesak H, Pedersen BL, et al. Danish Adverse Event Study. Incidence of adverse events in hospitals: a retrospective study of medical records. Ugeskr Laeger 2001; 163: 5370-8
4. Davis P, Lay-Yee R, Briant R, et al. Adverse events in New Zealand public hospitals. I: Occurrence and impact [abstract]. N Z Med J 2002; 115: U268
5. Davis P, Lay-Yee R, Briant R, et al. Adverse events in New Zealand public hospitals. II: Preventability and clinical context [abstract]. N Z Med J 2003; 116: U624
6. Baker GR, Norton PG, Flintolf V, et al. The Canadian Adverse Events Study. The incidence of adverse events among hospital patients in Canada. Can Med Assoc J 2004; 179: 1678-86
7. Progress in essential drugs and medicines policy 1998-1999. Geneva: World Health Organization, 2000 WHO document WHO/EDM/2000.2
8. Issakov A. Health care equipment: a WHO perspective. In: van Grutting CWG, editor. Medical devices: international perspectives on health and safety. Amsterdam: Elsevier, 1994
9. Berwick DM, Leape LL. Reducing errors in medicine. Qual Health Care 1999; 8 (3): 145-6
10. World Alliance for Patient Safety: forward programme. Geneva: World Health Organization. 2004
11. Leape LL, Brennan TA, Laird N, et al. The nature of adverse events in hospitalized patients: results of the Harvard Medical Practice Study II. N Engl J Med 1991; 324 (6): 377-84
12. Smith R. The GMC: expediency before principle. BMJ 2005 Jan 1; 330 (7481): 1-2
13. Twisselmann B. The GMC: expediency before principle: summary of responses [letter]. BMJ 2005 Jan 29; 330 (7485): 254
14. Dyer C. GMC must protect patients says government minister [letter]. BMJ 2005 Feb 5; 330 (7486): 271
15. van Grootheest AC, Edwards IR. Labelling and 'Dear Doctor' letters: are they noncommittal? Drug Saf 2002; 25 (15): 1051-5
16. Dyer C. Judge dismisses test case on third generation pill [letter]. BMJ Aug 2002; 325: 237
17. Lindquist M, Edwards IR, Bate A, et al. From association to alert: a revised approach to international signal analysis. Pharmacoepidemiol Drug Saf 1999 Apr; 8 Suppl. 1: S15-25
18. Olsson S, Edwards IR. Tachycardia during cisapride treatment. BMJ 1992; 305 (6856): 748-9
19. Bowdler J. Effective communications in pharmacovigilance. Birmingham: W Lake Ltd, 1997
20. The Erice declaration: on communicating drug safety information [abstract]. Prescrire Int 1998 Dec; 7 (38): 191
21. Belton KJ, Lewis SC, Payne S, et al. Attitudinal survey of adverse drug reaction reporting by medical practitioners in the United Kingdom. Br J Clin Pharmacol 1995; 39 (3): 223-226